Stéphane Bancel, Moderna CEO (JPM20/Jeff Rumans)
November 11, 2020 04:38 PM ESTUpdated 04:51 PM
Coronavirus

Mod­er­na says it's reached the re­quired num­ber of Covid-19 cas­es for its first in­ter­im analy­sis. When is the read­out com­ing?

Max Gelman

Senior Editor

Pfiz­er and BioN­Tech came out with the first Phase III in­ter­im analy­sis of their Covid-19 vac­cine ear­li­er this week, and it ap­pears Mod­er­na is right …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

Rev­o­lu­tion Med­i­cines breaks ground in chal­leng­ing pan­cre­at­ic can­cer with two RAS drugs

CRISPR ther­a­py re­duces swelling at­tacks by 81% in In­tel­lia fol­low-up study

Up­dat­ed: Pfiz­er's ac­tivist says board must 'hold man­age­ment ac­count­able' for R&D short­com­ings

Q3 biotech roundup: The 2024 turn­around sput­ters in­to a crit­i­cal Q4 fi­nale

Iterum wins ap­proval for new oral an­tibi­ot­ic for UTIs. Now it wants a part­ner

sponsored

IDEAYA Bio­sciences: Tar­get­ing un­met mar­ket needs with pre­ci­sion on­col­o­gy

A service from the Financial Times